EMA Panel Backs Budesonide/Formoterol Hybrid for Asthma, COPD EMA Panel Backs Budesonide/Formoterol Hybrid for Asthma, COPD

The CHMP has endorsed the hybrid medicine Budesonide/Formoterol Teva Pharma B.V., a duplicate of DuoResp Spiromax, for adults with asthma and chronic obstructive pulmonary disease.International Approvals
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pulmonary Medicine News Alert Source Type: news